Search

Your search keyword '"Power, David"' showing total 91 results

Search Constraints

Start Over You searched for: Author "Power, David" Remove constraint Author: "Power, David" Publisher elsevier bv Remove constraint Publisher: elsevier bv
91 results on '"Power, David"'

Search Results

1. The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury

3. TCT-168 Clinical Significance of Insulin- and Noninsulin-Dependent Diabetes in Patients Undergoing Percutaneous Revascularization of the Left Main Coronary Artery

4. TCT-509 Impact of Coronary Trifurcation Anatomy on Cardiovascular Outcomes in Unprotected Left Main Percutaneous Coronary Intervention.

5. TCT-511 Impact of Adjunctive Intravascular Imaging on Cardiovascular Outcomes in Unprotected Left Main Percutaneous Coronary Intervention at a High-Volume Center

6. TCT-626 Clinical Impact of Troponin and CK-MB Release After Percutaneous Coronary Intervention With Rotational Atherectomy: Results From a Large Prospective Registry

8. LB-10 | Predictive Value of the Thrombotic Risk Criteria of the 2020 ESC guidelines for NSTE-ACS: Validation in a Large PCI Registry

9. TCT-158 Pooled Analysis of Patients Undergoing Complex PCI With the Dual-Therapy COMBO Stent: The MEGA-COMBO Complex-PCI Analysis

11. CE-543-04 INTER-ATRIAL BLOCK IDENTIFIES PATIENTS WITH LOW CHA2DS2-VASC SCORE BUT HIGH STROKE RISK

12. Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris

13. Cardiovascular Complications of Interatrial Conduction Block

14. IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL

16. IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL

18. Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI

19. TCT-38 Ticagrelor With and Without Aspirin in Patients With Previous Coronary Artery Bypass Graft Undergoing Percutaneous Coronary Intervention: The TWILIGHT-CABG Subanalysis

23. IMPACT OF TARGET VESSEL CHOICE ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH A PRIOR CORONARY ARTERY BYPASS GRAFT

24. PREVALENCE AND PROGNOSTIC IMPACT OF HIGH BLEEDING RISK STATUS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR LEFT MAIN CORONARY ARTERY DISEASE

26. A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease

27. Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry

28. Impact of Chronic Kidney Disease on Periprocedural Anticoagulation and Short-Term Outcomes after TAVR: A BRAVO-3 Trial Subanalysis

30. TCT CONNECT-305 Impact of Lesion Location on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Stenosis

31. TCT CONNECT-307 Long-Term Outcomes After Coronary Intervention With Drug Eluting Stents for Unprotected Left Main Coronary Artery Stenosis According to Diabetes Mellitus Status

34. Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial

35. A Systematic Review and Meta-analysis of Thrombotic Events Following Endovenous Thermal Ablation of the Great Saphenous Vein

38. Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: From the WIN-DES collaboration

40. A Systematic Review and Meta-analysis of Thrombotic Events Following Endovenous Thermal Ablation of the Great Saphenous Vein

42. Dominant protection from HLA-mediated autoimmune disease is conferred by antigen specific regulatory T cells

Catalog

Books, media, physical & digital resources